BREAKING: Fed, CPI Report In Focus
Oracle (ORCL) reported quarterly results late Monday that beat estimates as revenue jumped 18% and exceeded the high end of the company’s guidance. Oracle stock climbed as the software maker said it is investing heavily in health care information technology.
The database software company said adjusted earnings were $1.21 a share on revenue of $12.3 billion. Analysts expected Oracle to report earnings of $1.17 a share on revenue of $11.95 billion, according to FactSet.
In constant currency, revenue jumped 25%. The results were for Oracle’s fiscal second quarter ended Nov. 30.
Oracle stock rose 2.9% to 83.60 during after-hours trading on the stock market today.
“The strengthening of the U.S. dollar compared to foreign currencies had a significant impact on results in the quarter,” according to the Oracle earnings release. “Without the impact of the U.S. dollar strengthening, adjusted earnings would have been 9 cents higher.”
Total cloud revenue jumped 43% to $3.8 billion and was up 48% in constant currency, Oracle said.
Oracle is investing heavily to accelerate cloud revenue growth as it also moves to modernize health care information technology.
This was Oracle’s second quarter with a financial contribution from medical records company Cerner. Oracle acquired Cerner for $28 billion, as part of the software company’s deeper move into the health care sector. Cerner contributed $1.5 billion to total revenue.
“We are just beginning our mission to modernize health care information systems,” Oracle Chairman Larry Ellison said in a written statement with the earnings release. “In the wake of the Covid pandemic, there is a worldwide sense of urgency to transform and improve national health care systems. The scale of this opportunity is unprecedented.”
Please follow Brian Deagon on Twitter at @IBD_BDeagon for more on tech stocks, analysis and financial markets.
YOU MAY ALSO LIKE:
Best Growth Stocks To Buy And Watch: See Updates To IBD Stock Lists
How To Use The 10-Week Moving Average For Buying And Selling
Find The Best Long-Term Investments With IBD Long-Term Leaders
IBD Stocks On The Move: Watch For Breakouts Here
Inside The IBD 50: Top Stocks To Watch
12/12/2022 Dow Jones futures were lower ahead of Tuesday’s open after the Dow Jones industrials surged 528 points. Tesla stock neared…
12/12/2022 Dow Jones futures were lower ahead of Tuesday’s open after…
(© Gary Neill)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD’s investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor’s Business Daily, LLC. All rights reserved
